Associations between good days per month and migraine-related disease impact in the real-world: a post hoc analysis from the REVIEW study of eptinezumab in chronic migraine.

ABSTRACT:

SUBMITTER: Khan FA 

PROVIDER: S-EPMC12750955 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature